推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Cancer Medicine

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CANCER MED-US最新评论:你最后结果咋样了?我pending decision 8天了 (2024-03-25)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Cancer Medicine期刊基本信息Hello,您是该期刊的第163056位访客

基本信息 登录收藏
期刊名字Cancer MedicineCancer Medicine

CANCER MED-US
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.4
55人评分
我要评分

声誉
7.1

影响力
5.3

速度
8.3

期刊ISSN2045-7634
微信扫码收藏此期刊
2022-2023最新影响因子
(数据来源于搜索引擎)
4 点击查看影响因子趋势图
实时影响因子 截止2023年12月27日:2.556
2022-2023自引率2.50%点击查看自引率趋势图
五年影响因子4.5
h-index 34
CiteScore
CiteScoreSJRSNIPCiteScore排名
8.101.1881.130
学科分区排名百分位
大类:Medicine
小类:Radiology, Nuclear Medicine and Imaging
Q140 / 312
大类:Medicine
小类:Oncology
Q175 / 366
大类:Medicine
小类:Cancer Research
Q272 / 214

期刊简介
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:

Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations

Cancer Biology:
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery.

Cancer Prevention:
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach.

Bioinformatics:
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers.


Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
期刊官方网站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2045-7634
期刊投稿网址https://mc.manuscriptcentral.com/cancermedicine
期刊语言要求Language
Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Medicine的语言要求,还能让Cancer Medicine编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Medicine编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( EUR2300; GBP1950; USD3025; )
文章处理费豁免:查看说明

其他费用:没有
期刊主题关键词:cancer biology、cancer medicine、cancer prevention、bioinformatics
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardDouble blind peer review
通讯方式111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774
出版商John Wiley and Sons Ltd
涉及的研究方向ONCOLOGY-
出版国家或地区UNITED STATES
出版语言English
出版周期
出版年份0
年文章数 1015点击查看年文章数趋势图
Gold OA文章占比65.79%
研究类文章占比:
文章 ÷(文章 + 综述)
92.91%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:2区

按学科分区JIF分区JIF排名JIF百分位
学科:ONCOLOGY
类别:SCIE
Q296/241
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区2区2区
ONCOLOGY
肿瘤学
2区3区3区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区3区4区
ONCOLOGY
肿瘤学
2区2区3区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区3区1区
ONCOLOGY
肿瘤学
4区3区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2045-7634%5BISSN%5D
平均审稿速度网友分享经验:
19 Weeks
平均录用比例网友分享经验:
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Cancer Medicine顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Cancer Medicine期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Cancer Medicine中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Cancer Medicine上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE599551
    BIOMATERIALS512458
    BIOMEDICINE & PHARMACOTHERAPY461511
    Journal of Materials Chemistry B458194
    Frontiers in Pharmacology447970
    Frontiers in Immunology418810
    JOURNAL OF ETHNOPHARMACOLOGY403310
    COLLOIDS AND SURFACES B-BIOINTERFACES402946
    Frontiers in Oncology382266
    Acta Biomaterialia374417
  •  

    Cancer Medicine Cancer Medicine
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.First-line immunotherapy or angiogenesis inhibitor combined with chemotherapy for advanced non-small cell lung cancer with EGFR exon 20 insertions: Real-world evidence from China

    Author: Yang, Guangjian; Yang, Yaning; Liu, Runze; Li, Weihua; Xu, Haiyan; Hao, Xuezhi; Li, Junling; Zhang, Shuyang; Xu, Fei; Lei, Siyu; Wang, Yan
    Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 335-344. DOI: 10.1002/cam4.4852
        PubMed      DOI
    2.Identification of unique transcriptomic signatures and key genes through RNA sequencing and integrated WGCNA and PPI network analysis in HIV infected lung cancer

    Author: Wu, Liwei; Chen, Yongfang; Wan, Laiyi; Wen, Zilu; Liu, Rong; Li, Leilei; Song, Yanzheng; Wang, Lin
    Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 949-960. DOI: 10.1002/cam4.4853
        PubMed      DOI
    3.eEF1A1 promotes colorectal cancer progression and predicts poor prognosis of patients

    Author: Fan, A-hui; Zhao, Xiaojuan; Liu, Hao; Li, Danxiu; Guo, Tongtong; Zhang, Jiehao; Duan, Lili; Cheng, Hao; Nie, Yongzhan; Fan, Daiming; Zhao, Xiaodi; Lu, Yuanyuan
    Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 513-524. DOI: 10.1002/cam4.4848
        PubMed      DOI
    4.Construction of a prognostic glycolysis-related lncRNA signature for patients with colorectal cancer

    Author: Zhong, Xinyang; He, Xuefeng; Wang, Yaxian; Hu, Zijuan; Huang, Huixia; Zhao, Senlin; Zhang, Hong; Wei, Ping; Li, Dawei
    Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 930-948. DOI: 10.1002/cam4.4851
        PubMed      DOI
    5.Comparison of recurrence patterns in cervical cancer patients with positive lymph nodes versus negative

    Author: Ji, Mei; Liu, Yuan; Hu, Yan; Sun, Jing; Zhu, Haiyan
    Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 306-314. DOI: 10.1002/cam4.4860
        PubMed      DOI
    6.A real-world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non-small cell lung cancer

    Author: Zhang, Baihua; Xiao, Haifan; Pu, Xingxiang; Zhou, Chunhua; Yang, Desong; Li, Xu; Wang, Wenxiang; Xiao, Qin
    Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 274-286. DOI: 10.1002/cam4.4889
        PubMed      DOI
    7.Circulating tumor cells in neuroblastoma: Current status and future perspectives

    Author: Yang, Ran; Zheng, Shan; Dong, Rui
    Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 7-19. DOI: 10.1002/cam4.4893
        PubMed      DOI
    8.An exploratory clinical trial of apatinib combined with intensity-modulated radiation therapy for patients with unresectable hepatocellular carcinoma

    Author: Qiu, Hu; Ke, Shaobo; Cai, Gaoke; Wu, Yong; Wang, Jin; Shi, Wei; Chen, Jiamei; Peng, Jin; Yu, Baoping; Chen, Yongshun
    Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 213-222. DOI: 10.1002/cam4.4900
        PubMed      DOI
    9.The characteristics and clinical relevance of tumor fusion burden in head and neck squamous cell carcinoma

    Author: He, Lirui; Ren, Dandan; Lv, Guoqing; Mao, Beibei; Wu, Lijia; Liu, Xiaoyu; Gong, Longlong; Liu, Ping
    Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 852-861. DOI: 10.1002/cam4.4890
        PubMed      DOI
    10.Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients

    Author: Gao, Jianpeng; Huo, Shiying; Zhang, Yu; Zhao, Zhenxiong; Pan, Hongda; Liu, Xiaowen
    Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 913-929. DOI: 10.1002/cam4.4857
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共1206条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451